Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging

This study tested the hypothesis that diffusion tensor imaging can detect alteration in microscopic integrity of white matter and basal ganglia regions known to be involved in Parkinson's disease (PD) pathology. It was also hypothesized that there is an association between diffusion abnormality and PD severity and subtype. Diffusion tensor imaging at 4 Tesla was obtained in 12 PD and 20 control subjects, and measures of fractional anisotropy and mean diffusivity were evaluated using both region‐of‐interest and voxel‐based methods. Movement deficits and subtypes in PD subjects were assessed using the Motor Subscale (Part III) of the Unified Parkinson's Disease Rating Scale. Reduced fractional anisotropy (P < .05, corrected) was found in PD subjects in regions related to the precentral gyrus, substantia nigra, putamen, posterior striatum, frontal lobe, and the supplementary motor areas. Reduced fractional anisotropy in the substantia nigra correlated (P < .05, corrected) with the increased rating scale motor scores. Significant spatial correlations between fractional anisotropy alterations in the putamen and other PD‐affected regions were also found in the context of PD subtypes index analysis. Our data suggest that microstructural alterations detected with diffusion tensor might serve as a potential biomarker for PD. © 2011 Movement Disorder Society

[1]  Thomas E. Nichols,et al.  Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.

[2]  S. Lehéricy,et al.  Altered Diffusion in the Frontal Lobe in Parkinson Disease , 2008, American Journal of Neuroradiology.

[3]  Y. Assaf,et al.  Diffusion Tensor Imaging (DTI)-based White Matter Mapping in Brain Research: A Review , 2007, Journal of Molecular Neuroscience.

[4]  B Dan,et al.  Sensory and motor interfering influences on somatosensory evoked potentials. , 2000, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[5]  R. Barker,et al.  The search for biomarkers in Parkinson’s disease: a critical review , 2008, Expert review of neurotherapeutics.

[6]  D. Mikulis,et al.  A new sensitive imaging biomarker for Parkinson disease? , 2009, Neurology.

[7]  Susan M. Resnick,et al.  Morphometry of the human substantia nigra in ageing and Parkinson’s disease , 2008, Acta Neuropathologica.

[8]  Paul M. Matthews,et al.  MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study , 2009, NeuroImage.

[9]  E. Steyerberg,et al.  [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.

[10]  J D Speelman,et al.  [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[11]  Y Nakata,et al.  Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  W. Weiner,et al.  Parkinson's Disease: Diagnosis and Clinical Management , 2007 .

[13]  M. B. Spraker,et al.  High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease , 2009, Neurology.

[14]  Roger A. Barker,et al.  Understanding the dopaminergic deficits in Parkinson’s disease: Insights into disease heterogeneity , 2009, Journal of Clinical Neuroscience.

[15]  K. Jellinger,et al.  Recent developments in the pathology of Parkinson's disease. , 2002, Journal of neural transmission. Supplementum.

[16]  Khader M. Hasan,et al.  Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease , 2007, Neurobiology of Disease.

[17]  Alfonso Barrós-Loscertales,et al.  Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements , 2007, Brain Research.

[18]  Eileen O. Smith,et al.  Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease , 1995, Annals of neurology.

[19]  Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. , 1995, Neurosurgery.

[20]  C. Markham,et al.  Deficits in orofacial sensorimotor function in Parkinson's disease , 1986, Annals of neurology.

[21]  H. Bergman,et al.  Reduced basal activity and increased functional homogeneity in sensorimotor and striatum of a Parkinson's disease rat model: a functional MRI study , 2005, The European journal of neuroscience.

[22]  Schiess,et al.  Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. , 2000, Parkinsonism & related disorders.

[23]  Beate Ritz,et al.  Clinical characteristics in early Parkinson's disease in a central California population‐based study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[24]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[25]  J. O'Brien,et al.  Use of functional imaging in parkinsonism and dementia , 2003, Movement disorders : official journal of the Movement Disorder Society.

[26]  D. Brooks Neuroimaging in Parkinson’s disease , 2004, NeuroRX.

[27]  A. Leemans,et al.  Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract , 2009, NMR in biomedicine.

[28]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[29]  D. C. Howell Statistical Methods for Psychology , 1987 .

[30]  P. Blumbergs,et al.  Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson’s disease and dementia with Lewy bodies , 2008, Acta Neuropathologica.

[31]  Chaozhe Zhu,et al.  Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease. , 2011, European journal of radiology.

[32]  Aldo Quattrone,et al.  Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[33]  Alan C. Evans,et al.  A Three-Dimensional Statistical Analysis for CBF Activation Studies in Human Brain , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations , 2003, Movement disorders : official journal of the Movement Disorder Society.

[35]  M. Torrens Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[36]  D. Brooks The role of the basal ganglia in motor control: contributions from PET , 1995, Journal of the Neurological Sciences.

[37]  J. Rauschecker Compensatory plasticity and sensory substitution in the cerebral cortex , 1995, Trends in Neurosciences.

[38]  C. Antke,et al.  In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders , 2009, Behavioural Brain Research.

[39]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[40]  C. Tranchant Parkinson's disease and nonmotor dysfunction , 2006 .

[41]  S Fook-Chong,et al.  Case control study of diffusion tensor imaging in Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[42]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[43]  M. Yaman,et al.  The effects of levodopa use on diffusion coefficients in various brain regions in Parkinson's disease , 2007, Neuroscience Letters.

[44]  M. Chesselet,et al.  Basal ganglia and movement disorders: an update , 1996, Trends in Neurosciences.

[45]  Robin M Heidemann,et al.  Generalized autocalibrating partially parallel acquisitions (GRAPPA) , 2002, Magnetic resonance in medicine.

[46]  Werner Jaschke,et al.  Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. , 2006, Brain : a journal of neurology.